Protect Your Liver: Weight Loss, Retatrutide, and DEXA Monitoring
Weight loss is about more than appearance — it’s critical for liver health. Many people with excess weight have nonalcoholic fatty liver disease, a common but often silent condition with serious consequences.
Clinical studies show 85% of patients treated with Retatrutide normalized liver fat levels, a stronger result than other GLP-1 agonists to date.
DEXA scans provide a reliable way to monitor visceral fat and track progress over time. Talk with your clinician about whether Retatrutide and DEXA monitoring fit your care plan.
